Trevi Therapeutics, Inc. TRVI Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -33.6%+21.5pp | -30.2%+22.4pp | -36.9%+22.8pp | -35.7%+12.3pp | -55.1%-16.6pp | |
| Return on invested capital | -45%+27.5pp | -42.6%+44.6pp | -57.8%+30.5pp | -75.3%-12.5pp | -72.5%-22.0pp | |
| Liquidity | ||||||
| Current ratio | 24.8×+9.4× | 19.7×+9.2× | 21.9×+14.6× | 22.4×+11.7× | 15.4×+0.8× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $1.18+39.8% | $1.36+39.2% | $1.31+125% | $1.52+133% | $0.85+16.3% | |
| Valuation | ||||||
| Market capitalization | $1.53B+152% | $1.61B+336% | $1.11B+230% | $702.53M+137% | $608.13M+77.2% | |
| Price / book | 8.9×+2.8× | 8.8×+5.1× | 5.9×+0.1× | 3.5×-0.9× | 6.1×+1.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Trevi Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Trevi Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.